FDA Objects To ‘Pretty Easy, Huh?’ TV Ad For Gvoke Injection Diabetes Drug

In its second letter of the year, US Office of Prescription Drug Promotion says Xeris Pharmaceuticals’ television ad fails to include important risk information and misleadingly suggests Gvoke pre-filled syringe can be easily used.

As seen on tv with retro television icon
FDA cites Xeris for misleading TV ad about diabetes drug Gvoke • Source: Shutterstock

The US Food and Drug Administration criticized Xeris Pharmaceuticals, Inc.'s Gvoke PFS (glucagon pre-filled syringe) television advertisement for leaving out serious risks associated with the diabetes drug and claiming it is easy to use.

In a 14 August

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Compliance